|
Volume 4 Issue 1
|
|
Comment |
|
|
Generic drug policy in Australia: a community pharmacy perspective
Grahame Beecroft Australia and New Zealand Health Policy 2007, 4:7 (1 June 2007)
Abstract | Full text | PDF | PubMed
|
|
|
Reshaping Australian drug policy: the dilemmas of generic medicines policy
Hans Löfgren Australia and New Zealand Health Policy 2007, 4:11 (1 June 2007)
Abstract | Full text | PDF | PubMed
|
|
|
Assessing outcomes of health and medical research: do we measure what counts or count what we can measure?
Robert Wells, Judith A Whitworth Australia and New Zealand Health Policy 2007, 4:14 (28 June 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Addressing men's health policy concerns in Australia: what can be done?
James A Smith Australia and New Zealand Health Policy 2007, 4:20 (10 October 2007)
Abstract | Full text | PDF | PubMed
|
|
Review |
|
|
Assessing the impact of prescribed medicines on health outcomes
Wayne D Hall, Jayne Lucke Australia and New Zealand Health Policy 2007, 4:1 (15 February 2007)
Abstract | Full text | PDF | PubMed
|
|
|
Towards enhancing national capacity for evidence informed policy and practice in falls management: a role for a "Translation Task Group"?
Roslyn G Poulos, Anthony B Zwi, Stephen R Lord Australia and New Zealand Health Policy 2007, 4:6 (31 May 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
Research |
|
|
The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines
Christine Y Lu, Kenneth M Williams, Richard O Day Australia and New Zealand Health Policy 2007, 4:2 (1 March 2007)
Abstract | Full text | PDF | PubMed
|
|
|
Determining appropriateness for rehabilitation or other subacute care: is there a role for utilisation review?
Christopher J Poulos, Kathy Eagar Australia and New Zealand Health Policy 2007, 4:3 (13 March 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
In what ways does the mandatory nature of Victoria's municipal public health planning framework impact on the planning process and outcomes?
Prue Bagley, Vivian Lin, Peter Sainsbury, Marilyn Wise, Tom Keating, Karen Roger Australia and New Zealand Health Policy 2007, 4:4 (22 March 2007)
Abstract | Full text | PDF | PubMed
|
|
|
The global biopharma industry and the rise of Indian drug multinationals: implications for Australian generics policy
Hans Löfgren Australia and New Zealand Health Policy 2007, 4:10 (1 June 2007)
Abstract | Full text | PDF | PubMed
|
|
|
Targeting services to reduce social inequalities in utilisation: an analysis of breast cancer screening in New South Wales
Stephen Birch, Marion Haas, Elizabeth Savage, Kees Van Gool Australia and New Zealand Health Policy 2007, 4:12 (5 June 2007)
Abstract | Full text | PDF | PubMed
|
|
|
Depression in multicultural Australia: Policies, research and services
Harry Minas, Steven Klimidis, Renata Kokanovic Australia and New Zealand Health Policy 2007, 4:16 (23 July 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
A pilot qualitative study of New Zealand policymakers' knowledge of, and attitudes to, the tobacco industry
Sheena Hudson, George Thomson, Nick Wilson Australia and New Zealand Health Policy 2007, 4:17 (25 July 2007)
Abstract | Full text | PDF | PubMed
|
|
|
Impact of telephone triage on emergency after hours GP Medicare usage: a time-series analysis
David Dunt, Robert Wilson, Susan E Day, Margaret Kelaher, Lyle Gurrin Australia and New Zealand Health Policy 2007, 4:21 (10 October 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Analysing NSW state policy for child obesity prevention: strategic policy versus practical action
Lesley King, Caroline Turnour, Marilyn Wise Australia and New Zealand Health Policy 2007, 4:22 (15 October 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
The use and misuse of health research by parliamentary politicians during the development of a national smokefree law
George Thomson, Nick Wilson, Philippa Howden-Chapman Australia and New Zealand Health Policy 2007, 4:24 (6 December 2007)
Abstract | Full text | PDF | PubMed
|
|
|
The views of stakeholders on controlled access schemes for high-cost antirheumatic biological medicines in Australia
Christine Y Lu, Jan Ritchie, Ken Williams, Ric Day Australia and New Zealand Health Policy 2007, 4:26 (20 December 2007)
Abstract | Full text | PDF | PubMed
|
